Daniel Auld
Montreal, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Quantitative 1H-NMR spectroscopy identifies metabolites and lipoprotein subclasses associated with intermediate phenotypes of chronic diseases in the Japanese Nagahama Study.
Journal: Scientific reports
Published: April 04, 2025
Transcriptomic profiling of severe and critical COVID-19 patients reveals alterations in expression, splicing and polyadenylation.
Journal: Scientific reports
Published: September 10, 2024
Novel synaptic markers predict early tau pathology and cognitive deficit in an asymptomatic population at risk of Alzheimer's disease.
Journal: Molecular psychiatry
Published: May 23, 2024
PTPRS is a novel marker for early tau pathology and synaptic integrity in Alzheimer's disease.
Journal: bioRxiv : the preprint server for biology
Published: May 20, 2024
PTPRS is a novel marker for early Tau pathology and synaptic integrity in Alzheimer's disease.
Journal: Scientific reports
Published: March 21, 2024
MSR1 and NEP Are Correlated with Alzheimer's Disease Amyloid Pathology and Apolipoprotein Alterations.
Journal: Journal of Alzheimer's disease : JAD
Published: January 17, 2022
Association of a Total Cholesterol Polygenic Score with Cholesterol Levels and Pathological Biomarkers across the Alzheimer's Disease Spectrum.
Journal: Genes
Published: October 13, 2021
The Biobanque québécoise de la COVID-19 (BQC19)-A cohort to prospectively study the clinical and biological determinants of COVID-19 clinical trajectories.
Journal: PloS one
Published: December 23, 2020
Apolipoprotein B is a novel marker for early tau pathology in Alzheimer's disease.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: December 16, 2020
Last Updated: 09/26/2026